Results 1 to 10 of about 382,649 (338)
Hematopoietic stem-cell transplantation.
Stem Cells and Cloning: Advances and Applications, 2006 Correspondence: Mark Tuthill Department of Medical Oncology, Hammersmith Hospital, imperial College National Health Service Trust, Ducane Rd, London, w12 0HS, UK Tel +44 208 383 1000 Fax +44 207 6039679 email marktuthill@doctors.org.uk Abstract: More ...
M. Ende, F. I. Ende
semanticscholar +13 more sources
Blood Advances, 2021 Key Points Allogeneic hematopoietic stem cell transplantation is a curative option in patients with VEXAS syndrome and severe manifestations.
Ava Diarra +15 more
semanticscholar +1 more source
BMC Medical Genomics, 2022 Background Acute lymphoblastic leukemia (ALL) is a type of heterogeneous hematopoietic malignancy that accounts for approximately 20% of adult ALL. Although ALL complete remission (CR) rate has increased to 85–90% after induction chemotherapy, 40–50% of ...
Xin Zong +7 more
doaj +1 more source
Hematology, 2022 Objective To explore the efficacy and safety of thrombopoietin receptor agonists (TPO-RAs) without anti-thymocyte globulin (ATG) in ATG-naïve patients with aplastic anemia (AA) in a real-world setting.Methods We retrospectively evaluated treatment ...
Masaki Iino +3 more
doaj +1 more source
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation.
Blood, 2020 CMV reactivation remains one of the most common and life-threatening infectious complications following allogeneic hematopoietic stem cell transplantation (allo-HCT) in spite of novel diagnostic technologies, several novel prophylactic agents and further
H. Einsele, P. Ljungman, M. Boeckh
semanticscholar +1 more source
Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway
Cancer Cell International, 2022 Background Rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene result in 8p11 myeloproliferative syndrome (EMS), which is a rare and aggressive hematological malignancy that is often initially diagnosed as myelodysplastic ...
Xuehong Zhang +10 more
doaj +1 more source
Biomolecules & Biomedicine, 2023 Quantification of measurable residual disease (MRD) correlates with the risk of leukemia recurrence in adults with B-cell acute lymphoblastic leukemia (ALL).
Lei-Ming Cao +16 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Hepatocellular carcinoma (HCC) is the most prevalent subtype of liver cancer with a mortality rate of approximately 3–6/100,000 and is the third leading cause of cancer-related death worldwide.
Haina Wang +13 more
doaj +1 more source
Journal of Hematology & Oncology, 2017 Background The optimal monitoring schedules and cutoff minimal residual disease (MRD) levels for the accurate prediction of relapse at all time points after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain unclear in patients with t ...
Ya-Zhen Qin +14 more
doaj +1 more source
Bone Marrow Transplantation, 2019 Information on incidence, and factors associated with mortality is a prerequisite to improve outcome after hematopoietic stem cell transplantation (HSCT).
J. Styczyński +26 more
semanticscholar +1 more source